Editorial - Journal of Bacteriology and Infectious Diseases (2025) Volume 9, Issue 3

The Microbiology of Sepsis: Identifying Culprits in Critical Care

Lisa Aliberti ^*

Department of Nutrition and Food Science, University of Maryland, Maryland, United States

*Corresponding Author:

Lisa Aliberti
Department of Nutrition and Food Science,
University of Maryland, Maryland, United States
E-mail: lisaasI90@gmail.com

Received: 01-Jan-2025, Manuscript No. AABID-24-171188; Editor assigned: 03-Jan-2025, PreQC No. AABID-24-171188(PQ); Reviewed:16-Jan-2025, QC No. AABID-24-171188; Revised:18-Jan-2025, Manuscript No. AABID-24-171188(R); Published: 24-Jan-2025, DOI:10.35841/aabid-9.2.209

Citation: Aliberti L. The microbiology of sepsis: Identifying culprits in critical care. J Bacteriol Infec Dis. 2025; 9(3):209

Introduction

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. It remains a major challenge in critical care, responsible for significant morbidity and mortality worldwide. Despite advances in supportive care and antimicrobial therapy, early identification of the microbial culprits behind sepsis is essential for effective treatment and improved outcomes. Clinical microbiology plays a pivotal role in diagnosing sepsis, guiding targeted therapy, and informing infection control strategies. Sepsis can arise from infections in virtually any part of the body, including the lungs, urinary tract, abdomen, and bloodstream. The condition is not caused by a single pathogen but rather a wide array of bacteria, fungi, and occasionally viruses. Staphylococcus aureus, including methicillin-resistant strains (MRSA), and Streptococcus pneumoniae are frequent causes [1].

Host factors such as age, comorbidities, immune status, and prior antibiotic exposure influence susceptibility to specific pathogens. For example, neutropenic patients are more prone to infections with Pseudomonas and Candida, while elderly patients may present atypically and harbor resistant organisms. Routine microbiological surveillance in hospitals helps track pathogen prevalence and resistance trends. This data informs empiric therapy guidelines and supports antimicrobial stewardship programs aimed at optimizing antibiotic use and reducing resistance. Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii are prominent in hospital-acquired infections. Candida species, particularly Candida albicans, are increasingly recognized in immunocompromised patients. Though less common, organisms like Bacteroides fragilis and Mycoplasma can contribute to sepsis. Bloodstream infections (BSIs) are a primary source of sepsis. Bacteremia—the presence of bacteria in the blood—is a hallmark of systemic infection. Blood cultures remain the gold standard for identifying pathogens in sepsis, though they are limited by time delays and sensitivity. Studies show that up to 30% of septic patients may have negative blood cultures, especially if antibiotics were administered prior to sample collection [2].

Traditional blood cultures require 24–72 hours for growth and identification. While essential for antimicrobial susceptibility testing (AST), they may miss fastidious or slow-growing organisms. PCR-based assays detect microbial DNA directly from blood samples, offering rapid results. Multiplex PCR panels can identify multiple pathogens and resistance genes simultaneously, improving diagnostic speed and accuracy. MALDI-TOF enables rapid identification of bacteria and fungi from positive blood cultures based on protein profiles. It significantly reduces turnaround time compared to conventional biochemical methods [3].

NGS provides comprehensive analysis of microbial genomes and metagenomes, identifying pathogens even in culture-negative sepsis. Though currently limited by cost and complexity, NGS holds promise for future diagnostics. Antimicrobial resistance (AMR) complicates sepsis management. Multidrug-resistant organisms (MDROs) such as MRSA, extended-spectrum beta-lactamase (ESBL)-producing E. coli, and carbapenem-resistant Klebsiella are increasingly implicated in sepsis cases. Rapid detection of resistance markers is crucial for guiding effective therapy and preventing treatment failure [4].

Commonly caused by S. pneumoniae, Legionella, and P. aeruginosa. Frequently involves E. coli, Klebsiella, and Enterococcus species. Often polymicrobial, including anaerobes like Bacteroides and facultative organisms like Enterobacteriaceae. Typically involves skin flora such as S. epidermidis and S. aureus. Understanding these patterns helps clinicians anticipate likely pathogens and tailor empiric therapy accordingly. Fungal sepsis, particularly due to Candida species, is rising in prevalence among ICU patients, especially those with central venous catheters, broad-spectrum antibiotic use, or immunosuppression. Candida auris, a multidrug-resistant yeast, has emerged as a global threat due to its persistence in healthcare environments and resistance to multiple antifungal agents [5].

Conclusion

Sepsis is a complex syndrome with diverse microbial etiologies. Accurate and timely identification of pathogens is critical for effective treatment and improved outcomes in critical care. While traditional culture methods remain essential, molecular diagnostics and emerging technologies are enhancing our ability to detect and characterize sepsis-causing microbes. A multidisciplinary approach that integrates clinical microbiology, infectious disease expertise, and critical care is vital to combat this global health challenge.

References

1. Pahalagedara AS, Jauregui R, Maclean P, et al. Culture and genome-based analysis of four soil Clostridium isolates reveal their potential for antimicrobial production. BMC genomics. 2021;22:1-4.

Indexed at, Google Scholar, Cross Ref

2. Xing P, Guo L, Tian W, et al. Novel Clostridium populations involved in the anaerobic degradation of Microcystis blooms. The ISME Journal. 2011;5(5):792-800.

Indexed at, Google Scholar, Cross Ref

3. Mehdizadeh Gohari I, A. Navarro M, Li J, et al. Pathogenicity and virulence of Clostridium perfringens. Virulence.2021;12(1):723-53.

Indexed at, Google Scholar, Cross Ref

4. Li J, Adams V, Bannam TL, et al. Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev.2013;77(2):208-33.

Indexed at, Google Scholar, Cross Ref

5. Pan CM, Fan YT, Zhao P, et al. Fermentative hydrogen production by the newly isolated Clostridium beijerinckii Fanp3. Int J Hydrog Energy. 2008;33(20):5383-91.

Google Scholar